XML 118 R89.htm IDEA: XBRL DOCUMENT v3.25.4
Taxation - Schedule of Weighted Average Tax Rate (Details) - USD ($)
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Schedule of Weighted Average Tax Rate [Abstract]      
(Loss) / earnings before income tax-rate $ (170,003,479) $ (27,958,152) $ 50,794,242
Income tax expense by applying tax rate in force in the respective countries 45,342,071 7,224,973 (7,628,367)
Share of profit or loss of subsidiaries, joint ventures and associates (8,232,869) (5,141,460) 12,645,224
Puttable instruments charge (3,645)
Stock options charge (167,601) (1,366,999) (586,774)
Derecognition of deferred tax assets [1] (40,565,962) (94,189) 428,530
Mutual funds adjustments 18,471 27,560
Non-deductible expenses (4,027,734) (1,469,872) (373,655)
Result of inflation effect on monetary items and other finance results 335,680 (5,113,890) (7,872,801)
Tax inflation adjustment 1,633,659 4,278,344 5,916,143
Rate change adjustment 118,060 (192,127)
Others (971,836) 434,321 (4,162)
Income tax expenses $ (6,636,121) $ (1,103,152) $ 2,328,366
[1] Mainly represent derecognition of deferred tax assets from Bioceres S.A. because it initiated the voluntary bankruptcy proceeding (Note 21).